MedPath

Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features

Completed
Conditions
Prostate Cancer
Interventions
Other: Observe
Registration Number
NCT06604377
Lead Sponsor
Ruijin Hospital
Brief Summary

The purpose of this study is to investigate the predictive value of preoperative 18F-PSMA-1007 PET/MR in the predictive effect of biological recurrence (BCR) after radical prostatectomy (RP) for localized prostate cancer (PCa).

Detailed Description

Construct a predictive model for biochemical recurrence (BCR) in patients after radical prostatectomy using imaging parameters from preoperative 18F-PSMA-1007 PET/MRI, and compare the predictive performance of this model with existing clinical models. Data from three centers will be collected, with datasets from two centers used as the training set for the selection of predictive factors and model construction, while the dataset from the remaining center will serve as the validation set to assess the predictive performance of the model for BCR after prostatectomy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
203
Inclusion Criteria
  1. Age ≥ 18 years
  2. Histologically confirmed prostate cancer without other types of malignancy -
Exclusion Criteria

1.Surgery or endocrine therapy is performed prior to the examination

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Shanghai East Hospital, Tongji University School of MedicineObservePatients diagnosed with prostate cancer undergoing PSMA PET/MR examination prior to surgery.
Primary Outcome Measures
NameTimeMethod
18F-PSMA-1007 PET/MR image parametersBefore surgery
Secondary Outcome Measures
NameTimeMethod
Biochemical recurrence-free survival time3 years

Trial Locations

Locations (1)

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath